<DOC>
	<DOCNO>NCT00696761</DOCNO>
	<brief_summary>Benign prostatic hyperplasia ( BPH ) common condition among old men . The efficacy α1-blockers treat BPH well document recommended treatment BPH clinical guideline . It well know stratification base grade BOO bladder contractility predictive value patient treat α1-selective blocking agent . In study , investigate possible difference treatment outcome patient without BOO , without proper contractility treat alfuzosin . So compare quantified improvement 12 month alfuzosin medication LUTS/BPH patient grade BOO and/or bladder contractility .</brief_summary>
	<brief_title>The Long Term Effects Alfuzosin ( Xatral XL ) Lower Urinary Tract Symptoms ( LUTS ) /BPH Patients</brief_title>
	<detailed_description>1 . Primary objective To evaluate efficacy void storage symptom LUTS/BPH patient 12 month treatment Xatral XL® grade bladder outlet obstruction and/or bladder contractility 2 . Secondary objective To evaluate efficacy void storage symptom LUTS/BPH patient 3 month 6 month treatment Xatral XL® grade bladder outlet obstruction and/or bladder contractility To evaluate efficacy maximal flow rate ( MFR ) post-voided residual urine ( PVR ) To evaluate voiding frequency , urgency severity &amp; frequency , nocturia To evaluate patient tolerability medication To evaluate global impression improvement ( GII )</detailed_description>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Urinary Bladder Neck Obstruction</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Ambulatory male ( ≥50 year ) suffer LUTS suggestive BPH Patients satisfy follow : Moderate severe LUTS : international prostate symptom score ( IPSS ) ≥ 8 An enlarged prostate ( ≥25 mL ) Decreased peak flow rate : Qmax ≤15 mL/s ( volume void ≥ 120 mL ) Post void residual urine ≥ 200 mL Patients perform catheterization Urinary tract infection patient Patients take 5 alpha reductase inhibitor Known hypersensitivity alfuzosin History postural hypotension syncope Hypertension patient treat alpha1blockers Patients newly take anticholinergic medication within 1 month Hepatic insufficiency ( Aspartate transaminase /alanine aminotransferase ≥ 2 time normal range ) Renal insufficiency ( sCr ≥ 2mg/dL ) Unstable angina pectoris Uninvestigated hematuria Serum Prostate specific antigen ≥ 4 ng/mL ( biopsy proven cancer patient include ) Interstitial cystitis patient Severe concomitant condition threaten life . Patient unable make void diary Bladder prostate cancer patient Patients receive prostate bladder surgery</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>LUTS</keyword>
	<keyword>BPH</keyword>
	<keyword>bladder outlet obstruction</keyword>
	<keyword>bladder contractility</keyword>
</DOC>